DocDollars

Stemline Therapeutics Inc.

NY · United States · Reporting entity ID 100000481815

Total reported 2019–2025
$32.3M
#223 of 2,960 reporting companies — 0% of all reported industry payments
$7.71M in general payments across 26,645 records, plus $24.6M in research funding across 4,068 records.

How it breaks down

General payments $7,714,333
Research funding $24,586,906

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Stemline Therapeutics Inc. reported $32.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #223 of 2,960 reporting companies. 76% of that was research funding and 24% general payments such as consulting, speaking, food and travel. 26,645 general payment records and 4,068 research records were filed.

Common questions about Stemline Therapeutics Inc.

How much has Stemline Therapeutics Inc. paid US doctors?

Stemline Therapeutics Inc. reported $32,301,239 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $7,714,333 in general payments, $24,586,906 in research funding.

How does Stemline Therapeutics Inc. rank among drug and device companies?

It ranks #223 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Stemline Therapeutics Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.